Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost savings compared to CRP alone The $9.95 Million Question: Is ESR Worth Keeping? A ...
ALCOR Scientific reports a study indicating that combining ESR and CRP tests may reduce misdiagnoses and save hospitals ...
The erythrocyte sedimentation rate (ESR) remains a widely used clinical assay to assess systemic inflammation by measuring the rate at which erythrocytes settle in anticoagulated blood over a fixed ...
C-met as a therapeutic target using ARQ 197 in renal cell carcinoma. Background: Systemic inflammation has been associated with increased tumor grade and disease progression in renal cell carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results